These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27480441)

  • 1. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
    Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H
    Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
    Jaafar MHM; Hamid KA
    Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit
    Lee SH; Back SY; Song JG; Han HK
    J Nanobiotechnology; 2020 Jul; 18(1):104. PubMed ID: 32711522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.
    Li X; Qi J; Xie Y; Zhang X; Hu S; Xu Y; Lu Y; Wu W
    Int J Nanomedicine; 2013; 8():23-32. PubMed ID: 23293517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo.
    Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C
    J Control Release; 2019 Nov; 313():1-13. PubMed ID: 31622690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.
    Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A
    Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.